You are viewing the site in preview mode

Skip to main content

Advertisement

Table 2 Patients’ demographics

From: Hospitalization for community-acquired febrile urinary tract infection: validation and impact assessment of a clinical prediction rule

  Control group Intervention group p
ITT = PP ITT PP Control vs ITT Control vs PP
n = 237 n = 133 n = 81   
Age in years; median, (IQR) 60 (30) 61 (34) 71 (26) ns <0,01
Sex – female 148 (62) 74 (56) 33 (41) ns <0,01
Febrile uncomplicated UTI 54 (23) 30 (23) 9 (11) ns 0,02
Antimicrobial treatment at inclusion 90 (38)a 44 (33) 22 (27) ns ns
Urologic history
 Present urinary catheter 17 (7) 9 (7) 8 (10) ns ns
 History of urinary tract disordera 73 (31) 33 (25) 29 (36) ns ns
 Recurrent UTIb 30 (13)c 11 (9)c 5 (7) ns ns
Comorbidity
 Any 124 (52) 77 (58) 57 (70) ns <0,01
 Diabetes mellitus 36 (15) 29 (22) 25 (31) ns <0,01
 Malignancy 13 (5) 11 (8) 10 (12) ns ns
 Heart failure 32 (13) 12 (9) 11 (14) ns ns
 Cerebrovascular disease 17 (7) 20 (15) 18 (22) 0.02 <0,01
 Cirrhosis 1 (0) 2 (1) 1 (1) ns ns
 Renal insufficiency 12 (5) 20 (15) 18 (22) <0.01 <0,01
 Immunocompromised 19 (8) 10 (8) 5 (6) ns ns
  1. Data are presented as n (%) unless otherwise stated. ITT intention to treat analysis, PP per protocol analysis, IQR interquartile range, ns not significant (at 0,05 level), UTI urinary tract infection. aUrinary tract disorder: presence of any functional or anatomical abnormality of the urinary tract excluding the presence of a urinary catheter. bRecurrent UTI: two or more episodes in the last 6 months or three or more episodes of UTI in the last year. cUTI history was unknown in 13 subjects in control period and 6 subjects in intervention period